The app raises awareness of the effects of Crohn’s disease or colitis by simulating what it is like to live with these conditions for 24 hours.
During the simulation, you can experience some of the challenges that people with Crohn's or Colitis face every day.
For example, how people with these conditions:
Tags: Health, Wellness & Care in the Community (HWCC) · Medical
“Ever wished that, just for a day, your friends and family could understand what it’s like to have Crohn’s or Colitis?
Crohn’s & Colitis UK have teamed up with pharmaceutical company Takeda UK to create In My Shoes: 24 Hours with Crohn’s or Colitis - an immersive app that will allow anyone to experience first-hand what it’s like to have Crohn’s or Colitis.
From depleting energy levels to managing pain, from rushing to the toilet to juggling work and a social life, the app will allow friends, family and anyone you want, to see first-hand how the condition can affect every part of your body, and every aspect of your life.
Don’t worry - after 24 hours they can return to their normal lives. But they’ll do so with a deeper understanding and appreciation of what you have to go through every day.
In My Shoes: 24 hours with Crohn’s or Colitis is a simulation experience to give the user an insight into the challenges faced by people living with these conditions. Crohn’s and Colitis affect people in many different ways, so the app aims to give a broad overview of the key symptoms and impact on daily living.
PatientView provides this website for use as information, or for educational purposes. We do not warrant that the information we provide on the website will meet your health or medical requirements. Contact a health professional if you are concerned about your health. Nor can we guarantee that the information we provide on the website will always be up to date or accurate. PatientView is providing details of apps recommended by patient groups, an act which does not imply PatientView’s endorsement of any app. PatientView is not responsible for third-party content. Read more for copyright considerations